دورية أكاديمية
A Metal-Polyphenol-Based Oxygen Economizer and Fenton Reaction Amplifier for Self-Enhanced Synergistic Photothermal/Chemodynamic/Chemotherapy.
| العنوان: | A Metal-Polyphenol-Based Oxygen Economizer and Fenton Reaction Amplifier for Self-Enhanced Synergistic Photothermal/Chemodynamic/Chemotherapy. |
|---|---|
| المؤلفون: | Shi H; School of Biomedical Engineering, Anhui Medical University, Hefei, 230032, P. R. China., Wang R; School of Biomedical Engineering, Anhui Medical University, Hefei, 230032, P. R. China., Cao HC; School of Biomedical Engineering, Anhui Medical University, Hefei, 230032, P. R. China., Guo HY; School of Public Health, Anhui Medical University, Hefei, 230032, P. R. China., Pan P; School of Pharmacy, Anhui Medical University, Hefei, 230032, P. R. China., Xiong CF; School of Biomedical Engineering, Anhui Medical University, Hefei, 230032, P. R. China., Zhang LJ; School of Biomedical Engineering, Anhui Medical University, Hefei, 230032, P. R. China., Yang Q; School of Biomedical Engineering, Anhui Medical University, Hefei, 230032, P. R. China., Wei S; School of Biomedical Engineering, Anhui Medical University, Hefei, 230032, P. R. China., Liu T; School of Biomedical Engineering, Anhui Medical University, Hefei, 230032, P. R. China. |
| المصدر: | Advanced healthcare materials [Adv Healthc Mater] 2023 Jul; Vol. 12 (18), pp. e2300054. Date of Electronic Publication: 2023 Apr 12. |
| نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101581613 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2192-2659 (Electronic) Linking ISSN: 21922640 NLM ISO Abbreviation: Adv Healthc Mater Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Weinheim : Wiley-VCH, 2012- |
| مواضيع طبية MeSH: | Doxorubicin*/pharmacology , Nanoparticles* , Neoplasms*/therapy, Humans ; Cell Line, Tumor ; Hydrogen Peroxide ; Hypoxia ; Iron ; Metals ; Oxygen ; Photothermal Therapy ; Drug Synergism |
| مستخلص: | To overcome the limitations of doxorubicin (DOX) chemotherapy, nanomedicines that integrate additional photothermal therapy (PTT) and chemodynamic therapy (CDT) strategies are highlighted as promising alternatives for the treatment of malignant tumors. However, time-consuming preparation processes, biosafety concerns, and the bottlenecks of individual therapeutic modalities often limit the practical applications of this strategy. To address these issues, this work designs an oxygen economizer that additionally serves as a Fenton reaction amplifier through the simple assembly of epigallocatechin gallate (EGCG), pluronic F-127 (PF127), iron (III) ions, and doxorubicin (DOX) for the enhancement of synergistic PTT/CDT/chemotherapy. The resulting nanoformulation, EFPD, can target mitochondria and inhibit cell respiration to reduce O (© 2023 Wiley-VCH GmbH.) |
| References: | a) K. Ganesh, J. Massagué, Nat. Med. 2021, 27, 34;. b) Y. Qu, B. Chu, X. Wei, M. Lei, D. Hu, R. Zha, L. Zhong, M. Wang, F. Wang, Z. Qian, J. Controlled Release 2019, 296, 93;. c) W. Wu, L. Yu, Q. Jiang, M. Huo, H. Lin, L. Wang, Y. Chen, J. Shi, J. Am. Chem. Soc. 2019, 141, 11531. a) N. Borys, M. W. Dewhirst, Adv. Drug Delivery Rev. 2021, 178, 113985;. b) T. Liu, C. F. Xiong, L. J. Zhang, G. H. Jiao, H. Shi, J. Feng, X. Z. Zhang, Adv. Healthcare Mater. 2023, 12, 2202045;. c) W. Cheng, J. Nie, N. Gao, G. Liu, W. Tao, X. Xiao, L. Jiang, Z. Liu, X. Zeng, L. Mei, Adv. Funct. Mater. 2017, 27, 1704135;. d) Z. Li, Y. Yu, W. Zeng, F. Ding, D. Zhang, W. Cheng, M. Wang, H. Chen, G. Pan, L. Mei, Small 2022, 18, 2201803;. e) Z. Li, Y. Yang, H. Wei, X. Shan, X. Wang, M. Ou, Q. Liu, N. Gao, H. Chen, L. Mei, J. Controlled Release 2021, 338, 719. a) S. Mazzucchelli, M. Bellini, L. Fiandra, M. Truffi, M. A. Rizzuto, L. Sorrentino, E. Longhi, M. Nebuloni, D. Prosperi, F. Corsi, OncoTargets Ther. 2017, 8, 8383;. b) A. Bandyopadhyay, L. Wang, J. Agyin, Y. Tang, S. Lin, I.-T. Yeh, K. De, L.-Z. Sun, PLoS One 2010, 5, e10365. a) J. Chen, X. Li, X. Zhao, Q. Wu, H. Zhu, Z. Mao, C. Gao, Bioact. Mater. 2018, 3, 347;. b) S. Hameed, P. Bhattarai, X. Liang, N. Zhang, Y. Xu, M. Chen, Z. Dai, Theranostics 2018, 8, 5501;. c) S. Gao, Y. Jin, K. Ge, Z. Li, H. Liu, X. Dai, Y. Zhang, S. Chen, X. Liang, J. Zhang, Adv. Sci. 2019, 6, 1902137;. d) C.-C. Xue, M.-H. Li, Y. Zhao, J. Zhou, Y. Hu, K.-Y. Cai, Y. Zhao, S.-H. Yu, Z. Luo, Sci. Adv. 2020, 6, eaax1346. a) K. Mortezaee, A. Narmani, M. Salehi, H. Bagheri, B. Farhood, H. Haghi-Aminjan, M. Najafi, Life Sci. 2021, 269, 119020;. b) A. Sharma, S. Özayral, J. S. Caserto, R. Ten Cate, N. M. Anders, J. D. Barnett, S. K. Kandala, E. Henderson, J. Stewart, E. Liapi, Int. J. Hyperthermia 2019, 36, 711;. c) B. Chen, C. Zhang, W. Wang, Z. Chu, Z. Zha, X. He, W. Zhou, T. Liu, H. Wang, H. Qian, ACS Nano 2020, 14, 14919;. d) X. Liu, P. Geng, N. Yu, Z. Xie, Y. Feng, Q. Jiang, M. Li, Y. Song, W. Lian, Z. Chen, J. Colloid Interface Sci. 2022, 615, 38;. e) W. Zeng, H. Zhang, Y. Deng, A. Jiang, X. Bao, M. Guo, Z. Li, M. Wu, X. Ji, X. Zeng, Chem. Eng. J. 2020, 389, 124494;. f) L. Zhou, C. Du, R. Zhang, C. Dong, Chin. Chem. Lett. 2021, 32, 561. Z. Tang, Y. Liu, M. He, W. Bu, Angew. Chem., Int. Ed. 2019, 58, 946. L.-S. Lin, T. Huang, J. Song, X.-Y. Ou, Z. Wang, H. Deng, R. Tian, Y. Liu, J.-F. Wang, Y. Liu, J. Am. Chem. Soc. 2019, 141, 9937. a) H. Zhu, S. Sarkar, L. Scott, I. Danelisen, M. A. Trush, Z. Jia, Y. R. Li, React. Oxyg. Species (Apex, NC) 2016, 1, 189;. b) K. B. Wallace, V. A. Sardao, P. J. Oliveira, Circ. Res. 2020, 126, 926. a) D. Valenti, L. de Bari, G. A. Manente, L. Rossi, L. Mutti, L. Moro, R. A. Vacca, Biochim. Biophys. Acta. 2013, 1832, 2085;. b) J. F. Stevens, J. S. Revel, C. S. Maier, Antioxid. Redox Signal 2018, 29, 1589;. c) T. Ha, M. K. Kim, K.-s. Park, W. Jung, H. Choo, Y. Chong, J. Agric. Food Chem. 2018, 66, 3850. Z. Li, Z. Chen, H. Chen, K. Chen, W. Tao, X.-k. Ouyang, L. Mei, X. Zeng, Bioact. Mater. 2022, 17, 49. M. S. Akash, K. Rehman, J. Control Release 2015, 209, 120. a) X. Wang, J.-J. Yan, L. Wang, D. Pan, R. Yang, Y. Xu, J. Sheng, Q. Huang, H. Zhao, M. Yang, Chem. Mater. 2018, 30, 4073;. b) K. Kim, M. Shin, M. Y. Koh, J. H. Ryu, M. S. Lee, S. Hong, H. Lee, Adv. Funct. Mater. 2015, 25, 2402. T. Liu, W. Liu, M. Zhang, W. Yu, F. Gao, C. Li, S.-B. Wang, J. Feng, X.-Z. Zhang, ACS Nano 2018, 12, 12181. D. K. Roper, W. Ahn, M. Hoepfner, J. Phys. Chem. C 2007, 111, 3636;. T. Liu, M. Zhang, W. Liu, X. Zeng, X. Song, X. Yang, X. Zhang, J. Feng, ACS Nano 2018, 12, 3917. J. Zhang, B. Gao, B. Ye, Z. Sun, Z. Qian, L. Yu, Y. Bi, L. Ma, Y. Ding, Y. Du, Adv. Mater. 2023, 35, 2208571. a) Y. Tang, Y. Ji, C. Yi, D. Cheng, B. Wang, Y. Fu, Y. Xu, X. Qian, Y. E. Choonara, V. Pillay, Theranostics 2020, 10, 8691;. b) A. Zhou, T. Fang, K. Chen, Y. Xu, Z. Chen, X. Ning, Small 2022, 18, 2106568. a) E. I. Deryugina, J. P. Quigley, Cancer Metastasis Rev. 2006, 25, 9;. b) J. X. Fan, D. W. Zheng, W. W. Mei, S. Chen, S. Y. Chen, S. X. Cheng, X. Z. Zhang, Small 2017, 13, 1702714. W. L. Liu, T. Liu, M. Z. Zou, W. Y. Yu, C. X. Li, Z. Y. He, M. K. Zhang, M. D. Liu, Z. H. Li, J. Feng, Adv. Mater. 2018, 30, 1802006. D. M. Gilkes, G. L. Semenza, D. Wirtz, Nat. Rev. Cancer 2014, 14, 430. S. Deng, Q. Wu, Y. Zhao, X. Zheng, N. Wu, J. Pang, X. Li, C. Bi, X. Liu, L. Yang, L. Liu, W. Su, Y. Wei, C. Gong, Nanoscale 2015, 7, 5270. |
| فهرسة مساهمة: | Keywords: cellular respiration inhibition; hydrogen peroxide production; photothermal therapy; synergistic therapy; tumor hypoxia |
| المشرفين على المادة: | 80168379AG (Doxorubicin) BBX060AN9V (Hydrogen Peroxide) E1UOL152H7 (Iron) 0 (Metals) S88TT14065 (Oxygen) |
| تواريخ الأحداث: | Date Created: 20230328 Date Completed: 20230726 Latest Revision: 20230909 |
| رمز التحديث: | 20230910 |
| DOI: | 10.1002/adhm.202300054 |
| PMID: | 36977362 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2192-2659 |
|---|---|
| DOI: | 10.1002/adhm.202300054 |